title: Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
authors.affiliation: Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA. changhu.chen@ucdenver.edu
authors.forename: Changhu
authors.initials: C
authors.lastname: Chen
authors.forename: Denise
authors.initials: D
authors.lastname: Damek
authors.forename: Laurie E
authors.initials: LE
authors.lastname: Gaspar
authors.forename: Allen
authors.initials: A
authors.lastname: Waziri
authors.forename: Kevin
authors.initials: K
authors.lastname: Lillehei
authors.forename: B K
authors.initials: BK
authors.lastname: Kleinschmidt-DeMasters
authors.forename: Monica
authors.initials: M
authors.lastname: Robischon
authors.forename: Kelly
authors.initials: K
authors.lastname: Stuhr
authors.forename: Kyle E
authors.initials: KE
authors.lastname: Rusthoven
authors.forename: Brian D
authors.initials: BD
authors.lastname: Kavanagh